{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:26:22Z","timestamp":1791509182735,"version":"4.3.4"},"reference-count":159,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jaad.2018.05.1260","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T22:30:04Z","timestamp":1530138604000},"page":"853-867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":218,"title":["Onychomycosis"],"prefix":"10.1016","volume":"80","author":[{"given":"Shari R.","family":"Lipner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2018.05.1260_bib2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/09546634.2016.1161156","article-title":"How do we measure efficacy of therapy in onychomycosis: patient, physician, and regulatory perspectives","volume":"27","author":"Gupta","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2018.05.1260_bib3","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1001\/jama.2016.16167","article-title":"Long-standing onychodystrophy in a young woman","volume":"316","author":"Lipner","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2018.05.1260_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaad.2009.04.062","article-title":"Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents","volume":"62","author":"Piraccini","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib5","first-page":"55","article-title":"Clinical study of onychomycosis: factors contributing to the prognosis and response rate according to each factor and summation of factors","volume":"10","author":"Kim","year":"2005","journal-title":"Korean J Med Mycol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000051640","article-title":"Onychomycosis and other superficial fungal infections of the foot in the elderly: a pan-European survey","volume":"202","author":"Pierard","year":"2001","journal-title":"Dermatology"},{"issue":"3 pt 2","key":"10.1016\/j.jaad.2018.05.1260_bib7","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0190-9622(96)90064-X","article-title":"Special patient populations: onychomycosis in the HIV-positive patient","volume":"35","author":"Gregory","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0190-9622(92)70163-A","article-title":"The spectrum of nail disease in patients with human immunodeficiency virus infection","volume":"27","author":"Daniel","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/myc.12350","article-title":"Evaluation of improvement of onychomycosis in HIV-infected patients after initiation of combined antiretroviral therapy without antifungal treatment","volume":"58","author":"Ruiz-Lopez","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2018.05.1260_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaip.2013.10.004","article-title":"A case of exuberant candidal onychomycosis in a child with hyper IgE syndrome","volume":"2","author":"Cobos","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaad.2018.05.1260_bib11","first-page":"191","article-title":"Disseminated Fusarium infection originating from paronychia in a neutropenic patient: a case report and review of the literature","volume":"85","author":"Bourgeois","year":"2010","journal-title":"Cutis"},{"issue":"suppl 2","key":"10.1016\/j.jaad.2018.05.1260_bib12","first-page":"32","article-title":"A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B","volume":"77","author":"Selleslag","year":"2006","journal-title":"Acta Biomed"},{"key":"10.1016\/j.jaad.2018.05.1260_bib13","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1365-2133.2006.07240.x","article-title":"Invasive aspergillosis due to subungual onychomycosis during treatment for non-Hodgkin lymphoma","volume":"154","author":"Cuetara","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4103\/0378-6323.37067","article-title":"Malassezia furfur onychomycosis in an immunosuppressed liver transplant recipient","volume":"73","author":"Ertam","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib15","first-page":"518","article-title":"Majocchi\u2019s granuloma after kidney transplantation","volume":"4","author":"Burg","year":"2006","journal-title":"Exp Clin Transpl"},{"key":"10.1016\/j.jaad.2018.05.1260_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000018174","article-title":"Prevalence of superficial dermatomycoses in 73 renal transplant recipients","volume":"199","author":"Virgili","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2018.05.1260_bib17","first-page":"390","article-title":"Recurrent proximal white subungual onychomycosis associated with a defect of the polymorphonuclear chemotaxis","volume":"9","author":"Gianni","year":"1999","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00000372-199612000-00011","article-title":"Onychomycosis and keratomycosis caused by Alternaria sp. A bipolar opportunistic infection in a wood-pulp worker on chronic steroid therapy","volume":"18","author":"Arrese","year":"1996","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1439-0507.1993.tb00765.x","article-title":"Relapsing severe Trichophyton rubrum infections in an immunocompromised host: evidence of onychomycosis as a source of reinfection based on lectin typing","volume":"36","author":"Gruseck","year":"1993","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2018.05.1260_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/09546630701243418","article-title":"Review of antifungal therapy and the severity index for assessing onychomycosis: part I","volume":"19","author":"Baran","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2018.05.1260_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1440-0960.1998.tb01477.x","article-title":"Factors that may affect the response of onychomycosis to oral antifungal therapy","volume":"39","author":"Gupta","year":"1998","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1468-3083.2009.03487.x","article-title":"Prognostic factors for cure following treatment of onychomycosis","volume":"24","author":"Sigurgeirsson","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jaad.2006.12.019","article-title":"Onychomycosis: diagnosis and definition of cure","volume":"56","author":"Scher","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 60","key":"10.1016\/j.jaad.2018.05.1260_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2133.2001.00045.x","article-title":"Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis","volume":"145","author":"Baran","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12545","article-title":"Topical antifungal treatment prevents recurrence of toenail onychomycosis following cure","volume":"30","author":"Shemer","year":"2017","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2018.05.1260_bib26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2340\/00015555768283","article-title":"Lateral edge nail involvement indicates poor prognosis for treating onychomycosis with the new systemic antifungals","volume":"76","author":"Baran","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib27","first-page":"633","article-title":"Onychomycosis: predisposed populations and some predictors of suboptimal response to oral antifungal agents","volume":"9","author":"Gupta","year":"1999","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib28","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archderm.141.11.1467","article-title":"A bipartite interaction between Pseudomonas aeruginosa and fungi in onychomycosis","volume":"141","author":"Foster","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1439-0507.2009.01788.x","article-title":"Fusarium solani onychomycosis of the thumbnail coinfected with Pseudomonas aeruginosa: report of two cases","volume":"54","author":"Yang","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2018.05.1260_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1468-3083.2007.02401.x","article-title":"Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?","volume":"22","author":"Shemer","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib31","first-page":"202","article-title":"Prognostic factors in onychomycosis treatment","volume":"3","author":"Lipner","year":"2015","journal-title":"J Infect Dis Ther"},{"key":"10.1016\/j.jaad.2018.05.1260_bib32","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1111\/j.1439-0507.2010.01928.x","article-title":"Cure rate, duration required for complete cure and recurrence rate of onychomycosis according to clinical factors in Korean patients","volume":"54","author":"Ko","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2018.05.1260_bib33","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jaad.2010.09.730","article-title":"Onychomycosis: a proposed revision of the clinical classification","volume":"65","author":"Hay","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3949\/ccjm.83a.14187","article-title":"Evaluation of nail lines: color and shape hold clues","volume":"83","author":"Lipner","year":"2016","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jaad.2018.05.1260_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2133.1998.02050.x","article-title":"Subungual dermatophytoma complicating dermatophyte onychomycosis","volume":"138","author":"Roberts","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1067\/mjd.2002.124699","article-title":"Dermatophytoma: recalcitrance to treatment because of existence of fungal biofilm","volume":"47","author":"Burkhart","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2018.05.1260_bib37","first-page":"6","article-title":"The Scoring Clinical Index for Onychomycosis (SCIO index)","volume":"7","author":"Sergeev","year":"2002","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.jaad.2018.05.1260_bib38","first-page":"1","article-title":"The two foot-one hand disease","volume":"13","author":"Curtis","year":"1964","journal-title":"Bull Assoc Milit Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib39","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1365-4362.1997.00237.x","article-title":"Two feet-one hand syndrome: a retrospective multicenter survey","volume":"36","author":"Daniel","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaad.2003.07.011","article-title":"Modulation of linear nail growth to treat diseases of the nail","volume":"50","author":"Geyer","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib41","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2133.2002.04606.x","article-title":"Terbinafine (Lamisil) treatment of toenail onychomycosis in patients with insulin-dependent and non-insulin-dependent diabetes mellitus: a multicentre trial","volume":"146","author":"Farkas","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib42","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/archdermatol.2011.267","article-title":"A new classification system for grading the severity of onychomycosis: onychomycosis Severity Index","volume":"147","author":"Carney","year":"2011","journal-title":"Arch Dermatol"},{"issue":"5 pt 1","key":"10.1016\/j.jaad.2018.05.1260_bib43","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/0190-9622(95)91454-4","article-title":"Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis","volume":"32","author":"Faergemann","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib44","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archderm.1995.01690200057011","article-title":"Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group","volume":"131","author":"Hofmann","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0190-9622(95)90187-6","article-title":"Short-duration treatment of fingernail dermatophytosis: a randomized, double-blind study with terbinafine and griseofulvin. LAGOS III Study Group","volume":"32","author":"Haneke","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2340\/0001555570137140","article-title":"Itraconazole in onychomycosis. Open and double-blind studies","volume":"70","author":"Walsoe","year":"1990","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib47","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1128\/AAC.37.10.2064","article-title":"Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole","volume":"37","author":"Korting","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2018.05.1260_bib48","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0190-9622(94)70112-1","article-title":"Antifungal agents: an overview. Part II","volume":"30","author":"Gupta","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2230.1989.tb00901.x","article-title":"In\u00a0vitro activity of terbinafine","volume":"14","author":"Clayton","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib50","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0733-8635(03)00034-2","article-title":"Management of onychomycosis in children","volume":"21","author":"Tosti","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2018.05.1260_bib53","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/BF01975038","article-title":"The new generation of antifungal drugs","volume":"7","author":"Stevens","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jaad.2018.05.1260_bib55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/00003495-199243020-00010","article-title":"A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses","volume":"43","author":"Balfour","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2018.05.1260_bib56","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0738-081X(91)90077-X","article-title":"Terbinafine: an oral and topical antifungal agent","volume":"9","author":"Shear","year":"1991","journal-title":"Clin Dermatol"},{"issue":"suppl 39","key":"10.1016\/j.jaad.2018.05.1260_bib57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2133.1992.tb00004.x","article-title":"Clinical significance of interactions with antifungal agents","volume":"126","author":"Breckenridge","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib58","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2125.1991.tb03963.x","article-title":"Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes","volume":"32","author":"Back","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib59","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/bjd.15854","article-title":"Clinical presentation of terbinafine-induced severe liver injury and the value of laboratory monitoring: a critically appraised topic","volume":"177","author":"Kramer","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib60","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/bjd.13358","article-title":"British Association of Dermatologists\u2019 guidelines for the management of onychomycosis 2014","volume":"171","author":"Ameen","year":"2014","journal-title":"Br J Dermatol"},{"issue":"5 pt 1","key":"10.1016\/j.jaad.2018.05.1260_bib63","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S0190-9622(09)80305-8","article-title":"Mechanisms of action of systemic antifungal agents","volume":"28","author":"Elewski","year":"1993","journal-title":"J Am Acad Dermatol"},{"issue":"11-19","key":"10.1016\/j.jaad.2018.05.1260_bib64","first-page":"11","article-title":"The significance of itraconazole for treatment of fungal infections of skin, nails and mucous membranes","volume":"7","author":"Korting","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2018.05.1260_bib65","first-page":"23","article-title":"Fungal infections and their management","volume":"71","author":"Graybill","year":"1990","journal-title":"Br J Clin Pract Suppl"},{"key":"10.1016\/j.jaad.2018.05.1260_bib66","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF00558308","article-title":"The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects","volume":"36","author":"Van Peer","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib67","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/106002809202600411","article-title":"Itraconazole in antifungal therapy","volume":"26","author":"Cleary","year":"1992","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2018.05.1260_bib68","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0140-6736(92)90527-A","article-title":"Hepatic injury associated with itraconazole","volume":"340","author":"Lavrijsen","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2018.05.1260_bib69","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2133.1988.tb03229.x","article-title":"An evaluation of itraconazole in the management of onychomycosis","volume":"119","author":"Hay","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib70","first-page":"7","article-title":"Itraconazole","volume":"35","year":"1993","journal-title":"Med Lett Drugs Ther"},{"issue":"2 suppl 1","key":"10.1016\/j.jaad.2018.05.1260_bib71","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.12788\/j.sder.0016","article-title":"Current and emerging options in the treatment of onychomycosis","volume":"32","author":"Elewski","year":"2013","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2018.05.1260_bib72","series-title":"Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents","first-page":"263","article-title":"The toxicological properties of itraconazole","author":"Van Cauteren","year":"1987"},{"key":"10.1016\/j.jaad.2018.05.1260_bib73","first-page":"CD010031","article-title":"Oral antifungal medication for toenail onychomycosis","volume":"7","author":"Kreijkamp-Kaspers","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"suppl 3","key":"10.1016\/j.jaad.2018.05.1260_bib74","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1093\/clinids\/12.Supplement_3.S318","article-title":"Pharmacokinetics and tissue penetration of fluconazole in humans","volume":"12","author":"Brammer","year":"1990","journal-title":"Rev Infect Dis"},{"issue":"6 pt 2","key":"10.1016\/j.jaad.2018.05.1260_bib75","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0190-9622(98)70490-6","article-title":"Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail","volume":"38","author":"Scher","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/09546634.2012.703308","article-title":"Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment","volume":"24","author":"Gupta","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2018.05.1260_bib77","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1345\/aph.1M165","article-title":"Efficacy of fluconazole for the treatment of onychomycosis","volume":"43","author":"Brown","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2018.05.1260_bib78","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/archinte.1991.00400050150032","article-title":"Fluconazole-related hepatotoxicity in patients with acquired immunodeficiency syndrome","volume":"151","author":"Mu\u00f1oz","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2018.05.1260_bib79","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40257-013-0056-2","article-title":"Oral therapy for onychomycosis: an evidence-based review","volume":"15","author":"de Sa","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib80","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1468-3083.2012.04584.x","article-title":"Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta-analysis of efficacy for continuous and intermittent regimens","volume":"27","author":"Gupta","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib81","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1468-3083.2002.00589.x","article-title":"Onychomycosis: strategies to improve efficacy and reduce recurrence","volume":"16","author":"Gupta","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib82","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1046\/j.1365-2133.2002.05035.x","article-title":"Prognostic factors of mycological cure following treatment of onychomycosis with oral antifungal agents","volume":"147","author":"Sigurgeirsson","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib83","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1067\/mjd.2001.110874","article-title":"Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly","volume":"44","author":"Gupta","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib84","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-4362.2000.00964.x","article-title":"An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents","volume":"39","author":"Gupta","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib85","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/idoj.IDOJ_169_17","article-title":"Treatment of dermatophytosis in elderly, children, and pregnant women","volume":"8","author":"Kaul","year":"2017","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jaad.2018.05.1260_bib86","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/pde.12048","article-title":"Systemic antifungals to treat onychomycosis in children: a systematic review","volume":"30","author":"Gupta","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib87","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1517\/17425240802497218","article-title":"Enhancing the nail permeability of topically applied drugs","volume":"5","author":"Murdan","year":"2008","journal-title":"Exp Opin Drug Deliv"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2018.05.1260_bib88","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1468-3083.2005.01284.x","article-title":"Treatment options\u2014development of consensus guidelines","volume":"19","author":"Lecha","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib89","first-page":"253","article-title":"Clinical insights about onychomycosis and its treatment: a consensus","volume":"17","author":"Hanna","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib90","first-page":"58","article-title":"Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early","volume":"14","author":"Rich","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib91","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1586\/17512433.2015.1083418","article-title":"Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail","volume":"8","author":"Lipner","year":"2015","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib92","first-page":"42","article-title":"Onychomycosis of toenails and post-hoc analyses with efinaconazole 10% solution once-daily treatment: impact of disease severity and other concomitant associated factors on selection of therapy and therapeutic outcomes","volume":"9","author":"Del Rosso","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib93","first-page":"492","article-title":"Management of onychomycosis and co-existing tinea pedis","volume":"14","author":"Lipner","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib95","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jac\/dki105","article-title":"Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans","volume":"55","author":"Lee","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaad.2018.05.1260_bib96","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.celrep.2012.12.021","article-title":"Fungicidal drugs induce a common oxidative-damage cellular death pathway","volume":"3","author":"Belenky","year":"2013","journal-title":"Cell Rep"},{"issue":"4 suppl","key":"10.1016\/j.jaad.2018.05.1260_bib97","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1067\/mjd.2000.109072","article-title":"Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis","volume":"43","author":"Bohn","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib101","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","article-title":"Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies","volume":"68","author":"Elewski","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib102","first-page":"34","article-title":"Penetration of ((14)C)-efinaconazole topical solution, 10%, does not appear to be influenced by nail polish","volume":"7","author":"Zeichner","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib103","first-page":"89","article-title":"Evaluation of the appearance of nail polish following daily treatment of ex\u00a0vivo human fingernails with topical solutions of tavaborole or efinaconazole","volume":"15","author":"Vlahovic","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib104","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.1142189","article-title":"An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site","volume":"316","author":"Rock","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jaad.2018.05.1260_bib105","first-page":"675","article-title":"In\u00a0vitro nail penetration of tavaborole topical solution, 5%, through nail polish on ex\u00a0vivo human fingernails","volume":"14","author":"Vlahovic","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib106","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/09546634.2017.1422078","article-title":"In\u00a0vitro efficacy of tavaborole topical solution, 5% after penetration through nail polish on ex\u00a0vivo human fingernails","volume":"29","author":"Gupta","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2018.05.1260_bib107","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaad.2015.04.010","article-title":"Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: results from 2 randomized phase-III studies","volume":"73","author":"Elewski","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib108","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4103\/0378-6323.86475","article-title":"Onychomycosis: diagnosis and management","volume":"77","author":"Singal","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib109","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/pde.12064","article-title":"Onychomycosis does not always require systemic treatment for cure: a trial using topical therapy","volume":"30","author":"Friedlander","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/jof1010044","article-title":"Laser therapy for onychomycosis: fact or fiction?","volume":"1","author":"Liddell","year":"2015","journal-title":"J Fungi"},{"key":"10.1016\/j.jaad.2018.05.1260_bib111","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/lsm.1136","article-title":"Extended theory of selective photothermolysis","volume":"29","author":"Altshuler","year":"2001","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jaad.2018.05.1260_bib112","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.6836297","article-title":"Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation","volume":"220","author":"Anderson","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.jaad.2018.05.1260_bib113","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/aem.35.2.274-277.1978","article-title":"Survival and resistance of Trichophyton mentagrophytes arthrospores","volume":"35","author":"Hashimoto","year":"1978","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib114","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jaad.2013.04.054","article-title":"Treatment of onychomycosis using a submillisecond 1064-nm neodymium:yttrium-aluminum-garnet laser","volume":"69","author":"Carney","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/lsm.1900060118","article-title":"Effects of argon, dye, and Nd:YAG lasers on epidermis, dermis, and venous vessels","volume":"6","author":"Landthaler","year":"1986","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jaad.2018.05.1260_bib116","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1523-1747.2000.00150.x","article-title":"Detection of xanthomegnin in epidermal materials infected with Trichophyton rubrum","volume":"115","author":"Gupta","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib117","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10103-007-0492-4","article-title":"The effects of laser irradiation on Trichophyton rubrum growth","volume":"23","author":"Vural","year":"2008","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.jaad.2018.05.1260_bib118","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/jdv.14212","article-title":"A critical review of improvement rates for laser therapy used to treat toenail onychomycosis","volume":"31","author":"Gupta","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib119","unstructured":"Lee K, Onwudiwe O, Farinelli W, Garibyan L, Anderson RR. Absorption spectra of onychomycotic nails. Paper presented at: Laser 2015 American Society for Laser Medicine and Surgery Conference. April 24-26, 2015; Kissimee, FL."},{"key":"10.1016\/j.jaad.2018.05.1260_bib120","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaad.2013.12.024","article-title":"Lack of efficacy with 1064-nm neodymium:yttrium-aluminum-garnet laser for the treatment of onychomycosis: a randomized, controlled trial","volume":"70","author":"Hollmig","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib121","first-page":"1258","article-title":"Comparison of the efficacy of long-pulsed Nd:YAG laser intervention for treatment of onychomycosis of toenails or fingernails","volume":"13","author":"Li","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib122","first-page":"1237","article-title":"Prospective efficacy and safety evaluation of laser treatments with real-time temperature feedback for fungal onychomycosis","volume":"12","author":"Waibel","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib123","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/jdv.13798","article-title":"Treating onychomycosis with the short-pulsed 1064-nm-Nd:YAG laser: results of a prospective randomized controlled trial","volume":"31","author":"Karsai","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib124","first-page":"322","article-title":"Treatment of onychomycosis using the 1064 nm Nd:YAG laser: a clinical pilot study","volume":"12","author":"Hees","year":"2014","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2018.05.1260_bib125","first-page":"496","article-title":"Treating onychomycoses of the toenail: clinical efficacy of the sub-millisecond 1,064 nm Nd:YAG laser using a 5 mm spot diameter","volume":"11","author":"Kimura","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib126","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3314\/mmj.54.333","article-title":"Treatment of onychomycosis using a 1064nm Nd:YAG laser","volume":"54","author":"Noguchi","year":"2013","journal-title":"Med Mycol J"},{"key":"10.1016\/j.jaad.2018.05.1260_bib127","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000368348","article-title":"1,064-nm diode laser therapy of onychomycosis: results of a prospective open treatment of 82 toenails","volume":"230","author":"Renner","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2018.05.1260_bib128","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3109\/09546634.2014.975671","article-title":"A retrospective chart review of the clinical efficacy of Nd:YAG 1064-nm laser for toenail onychomycosis","volume":"26","author":"Gupta","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2018.05.1260_bib129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7547\/1020169","article-title":"Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure: some follow-up observations at 270 days","volume":"102","author":"Landsman","year":"2012","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.jaad.2018.05.1260_bib130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.7547\/1000166","article-title":"Treatment of mild,\u00a0moderate, and severe onychomycosis using 870- and 930-nm light exposure","volume":"100","author":"Landsman","year":"2010","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.jaad.2018.05.1260_bib131","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jaad.2014.01.893","article-title":"Toenail onychomycosis treated with a fractional carbon-dioxide laser and topical antifungal cream","volume":"70","author":"Lim","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib132","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1590\/abd1806-4841.20153588","article-title":"The association of fractional CO2 laser 10.600nm and photodynamic therapy in the treatment of onychomycosis","volume":"90","author":"de Oliveira","year":"2015","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib133","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2340\/00015555-0811","article-title":"Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: preliminary results of a single-centre open trial","volume":"90","author":"Sotiriou","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib134","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1590\/abd1806-4841.20142197","article-title":"Distal and lateral toenail onychomycosis caused by Trichophyton rubrum: treatment with photodynamic therapy based on methylene blue dye","volume":"89","author":"Souza","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib135","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.abb.2008.02.015","article-title":"The biochemistry of heme biosynthesis","volume":"474","author":"Heinemann","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jaad.2018.05.1260_bib136","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1562\/0031-8655(2001)074<0656:THOPAP>2.0.CO;2","article-title":"The history of photodetection and photodynamic therapy","volume":"74","author":"Ackroyd","year":"2001","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib137","first-page":"2628","article-title":"Photoradiation therapy for the treatment of malignant tumors","volume":"38","author":"Dougherty","year":"1978","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2018.05.1260_bib138","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ymeth.2016.07.008","article-title":"In situ production of ROS in the skin by photodynamic therapy as a powerful tool in clinical dermatology","volume":"109","author":"Fonda-Pascual","year":"2016","journal-title":"Methods"},{"key":"10.1016\/j.jaad.2018.05.1260_bib139","first-page":"3697","article-title":"Effects of laser irradiation on Trichophyton rubrum growth and ultrastructure","volume":"125","author":"Xu","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jaad.2018.05.1260_bib140","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10103-017-2379-3","article-title":"Effect of methylene blue-mediated antimicrobial photodynamic therapy on dentin caries microcosms","volume":"33","author":"Mendez","year":"2018","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.jaad.2018.05.1260_bib141","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/myc.12652","article-title":"In\u00a0vitro fungicidal effects of methylene blue at 625-nm","volume":"60","author":"Guffey","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.jaad.2018.05.1260_bib142","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archdermatol.2007.17","article-title":"Successful treatment of toenail onychomycosis with photodynamic therapy","volume":"144","author":"Watanabe","year":"2008","journal-title":"Arch Dermatol"},{"issue":"5 suppl","key":"10.1016\/j.jaad.2018.05.1260_bib143","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.jaad.2008.06.015","article-title":"Photodynamic therapy of onychomycosis caused by Trichophyton rubrum","volume":"59","author":"Piraccini","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib144","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaad.2010.06.008","article-title":"Treatment of refractory fingernail onychomycosis caused by nondermatophyte molds with methylaminolevulinate photodynamic therapy","volume":"65","author":"Gilaberte","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib145","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ad.2012.07.020","article-title":"Photodynamic therapy with methyl-aminolevulinate can be useful in the management of Scytalidium infections","volume":"104","author":"Aspiroz","year":"2013","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaad.2018.05.1260_bib146","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1099\/jmm.0.000133","article-title":"Inhibitory effect of silver nanoparticles mediated by atmospheric pressure air cold plasma jet against dermatophyte fungi","volume":"64","author":"Ouf","year":"2015","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib147","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2217\/fmb.13.86","article-title":"Contact-free inactivation of Trichophyton rubrum and Microsporum canis by cold atmospheric plasma treatment","volume":"8","author":"Heinlin","year":"2013","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib148","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/ced.12973","article-title":"Pilot study to evaluate a plasma device for the treatment of onychomycosis","volume":"42","author":"Lipner","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib149","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2133.2011.10660.x","article-title":"A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis","volume":"166","author":"Elewski","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib150","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/AAC.04902-14","article-title":"VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model","volume":"59","author":"Garvey","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2018.05.1260_bib151","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00333-17","article-title":"The tetrazole VT-1161 is a potent inhibitor of Trichophyton rubrum through its inhibition of T rubrum CYP51","volume":"61","author":"Warrilow","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2018.05.1260_bib152","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1016\/j.bmcl.2014.05.068","article-title":"Design and optimization of highly-selective fungal CYP51 inhibitors","volume":"24","author":"Hoekstra","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jaad.2018.05.1260_bib153","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.bmcl.2017.06.037","article-title":"Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors","volume":"27","author":"Yates","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jaad.2018.05.1260_bib154","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00779-17","article-title":"In\u00a0vitro human onychopharmacokinetic and pharmacodynamic analyses of ME1111, a new topical agent for onychomycosis","volume":"62","author":"Kubota-Ishida","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2018.05.1260_bib155","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1002\/jps.21711","article-title":"Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis","volume":"98","author":"Nair","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.jaad.2018.05.1260_bib156","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1007\/s11095-009-9934-y","article-title":"An ex\u00a0vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine","volume":"26","author":"Nair","year":"2009","journal-title":"Pharm Res"},{"key":"10.1016\/j.jaad.2018.05.1260_bib157","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.7863\/jum.2011.30.12.1723","article-title":"Ultrasound-mediated nail drug delivery system","volume":"30","author":"Abadi","year":"2011","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.jaad.2018.05.1260_bib158","doi-asserted-by":"crossref","DOI":"10.1002\/jum.14526","article-title":"Ultrasound-enhanced drug delivery for treatment of onychomycosis","author":"Kline-Schoder","year":"2018","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.jaad.2018.05.1260_bib159","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2340\/00015555-2874","article-title":"Laser-assisted photodynamic therapy or laser-assisted amorolfine lacquer delivery for treatment of toenail onychomycosis: an open-label comparative study","volume":"98","author":"Koren","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib160","doi-asserted-by":"crossref","first-page":"699","DOI":"10.5021\/ad.2017.29.6.699","article-title":"Randomized clinical trial to evaluate the efficacy and safety of combination therapy with short-pulsed 1,064-nm neodymium-doped yttrium aluminium garnet laser and amorolfine nail lacquer for onychomycosis","volume":"29","author":"Park","year":"2017","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib161","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/09546634.2016.1151856","article-title":"An open comparative study of nail drilling as adjunctive treatment for toenail onychomycosis","volume":"27","author":"Shemer","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2018.05.1260_bib162","first-page":"974","article-title":"Rapid treatment of subungual onychomycosis using controlled micro nail penetration and terbinafine solution","volume":"15","author":"Bristow","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib163","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1517\/14656566.2012.681779","article-title":"New therapeutic options for onychomycosis","volume":"13","author":"Gupta","year":"2012","journal-title":"Expert Opin Pharmacother"},{"issue":"suppl 65","key":"10.1016\/j.jaad.2018.05.1260_bib164","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-2133.149.s65.5.x","article-title":"Onychomycosis in clinical practice: factors contributing to recurrence","volume":"149","author":"Scher","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000448056","article-title":"Onychomycosis: practical approaches to minimize relapse and recurrence","volume":"2","author":"Tosti","year":"2016","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.jaad.2018.05.1260_bib166","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1468-3083.2011.04176.x","article-title":"A study on the decontamination of insoles colonized by Trichophyton rubrum: effect of terbinafine spray powder 1% and terbinafine spray solution 1%","volume":"26","author":"Feuilhade de Chauvin","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2018.05.1260_bib167","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7547\/1020309","article-title":"Optimization of an infected shoe model for the evaluation of an ultraviolet shoe sanitizer device","volume":"102","author":"Ghannoum","year":"2012","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.jaad.2018.05.1260_bib168","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2310\/7750.2012.12068","article-title":"Sanitization of contaminated footwear from onychomycosis patients using ozone gas: a novel adjunct therapy for treating onychomycosis and tinea pedis?","volume":"17","author":"Gupta","year":"2013","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2018.05.1260_bib169","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11046-010-9347-9","article-title":"Infection risk by dermatophytes during storage and after domestic laundry and their temperature-dependent inactivation","volume":"171","author":"Hammer","year":"2011","journal-title":"Mycopathologia"}],"updated-by":[{"DOI":"10.1016\/j.jaad.2019.05.042","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000}}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221832187X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221832187X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:51:43Z","timestamp":1759272703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221832187X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":159,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S019096221832187X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.05.1260","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733534108.793561571","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Onychomycosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.05.1260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(19)30298-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}